| Hans-Günter Meyer-Thompson | international
Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design.
Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design.
Roy PJ, Kim KC, Suda K, Luo J, Wang X, Olejniczak D, Liebschutz JM.
Drug Alcohol Depend Rep. 2023 Mar;6:100135. doi: 10.1016/j.dadr.2023.100135. Epub 2023 Jan 20. PMID: 36694665; PMCID: PMC9851915.